Innate immunity in type C hepatitis

Hepatitis C Virus Disease: Immunobiology and Clinical Applications

Volumn , Issue , 2008, Pages 1-15

  Takehara, Tetsuo ^a   Hayashi, Norio ^b  

^a OSAKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866144333     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-71376-2_1     Document Type: Chapter

References (42)

1. Ahmad, A., Alvarez, F. (2004). Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. Journal of Leukocyte Biology, 76:743-759.
2. Akira, S., Uematsu, S., Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell, 124:783-801.
3. Armeanu, S., Bitzer, M., Lauer, U. M., Venturelli, S., Pathil, A., Krusch, M., Kaiser, S., Jobst, J., Smirnow, I., Wagner, A., Steinle, A., Salih, H. R. (2005). Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Research, 65:6321-6329.
4. Avila, M. A., Berasain, C., Sangro, B., Prieto, J. (2006). New therapies for hepatocellular carcinoma. Oncogene, 25:3866-3884.
5. Bahram, S., Bresnahan, M., Geraghty, D. E., Spies, T. (1994). A second lineage of mammalian major histocompatibility complex class I genes. Proceedings of the National Academy of Sciences of the United States of America, 91:6259-6263.
6. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., Spies, T. (1999). Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science, 285:727-729.
7. Biron, C. A. (2001). Interferons alpha and beta as immune regulators-A new look. Immunity, 6:661-664.
8. Butterfield, L. H. (2004). Immunotherapeutic strategies for hepatocellular carcinoma. Gastroenterology, 127:S232-S241.
9. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., Houghton, M. (1989). Isolation of cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244:359-362.
10. Dranoff, G. (2004). Cytokines in cancer pathogenesis and cancer therapy. Nature Reviews Cancer, 4:11-22.
11. Gasser, S., Orrulic, S., Brown, E. J., Raulet, D. H. (2005). The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature, 436:1186-1190.
12. Gerosa, F., Baldani-Guerra, B., Nisii, C., Marchesini, V., Carra, G., Trinchieri, G. (2002). Reciprocal activating interaction between natural killer cells and dendritic cells. Journal of Experimental Medicine, 195:327-333.
13. Golden-Mason, L., Rosen, H. R. (2006). Natural killer cells: primary target for hepatitis C virus immune evasion strategies? Liver Transplantation, 12:363-372.
14. Groh, V., Wu, J., Yee, C., Spies, T. (2002). Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature, 419:734-738.
15. Hayashi, N., Takehara, T. (2006). Anti-viral therapy for chronic hepatitis C: past, present, and future. Journal of Gastroenterology, 41:17-27.
16. Jinushi, M., Takehara, T., Kanto, T., Tatsumi, T., Groh, V., Spies, T., Miyagi, T., Suzuki, T., Sasaki, Y., Hayashi, N. (2003a). Critical role of MHC class I-related chain A and B expression on interferon a-stimulated dendritic cells in NK cell activation: Impairment in chronic hepatitis C virus infection. Journal of Immunology, 170:1249-1256.
17. Jinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Groh, V., Spies, T., Suzuki, T., Miyagi, T., Hayashi, N. (2003b). Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. Journal of Immunology, 171:5423-5429.
18. Jinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Groh, V., Spies, T., Kimura, R., Miyagi, T., Mochizuki, K., Sasaki, Y., Hayashi, N. (2003c). Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. International Journal of Cancer, 104:354-361.
19. Jinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Miyagi, T., Suzuki, T., Kanazawa, Y., Hiramatsu, N., Hayashi, N. (2004). Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. Journal of Immunology, 173:6072-6081.
20. Jinushi, M., Takehara, T., Tatsumi, T., Hiramatsu, N., Sakamori, R., Yamaguchi, S., Hayashi, N. (2005). Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. Journal of Hepatology, 43:1013-1020.
21. Jinushi, M., Takehara, T., Tatsumi, T., Yamaguchi, S., Sakamori, R., Hiramatsu, N., Kanto, T., Ohkawa, K., Hayashi, N. (2006). Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4+ CD25+ T cells with PD-1-dependent regulatory activities. Immunology, in press.
22. Kaisho, T., Akira, S. (2003). Regulation of dendritic cell function through Toll-like receptors. Current Molecular Medicine, 4:373-385.
23. Karre, K., Ljunggren, H. G., Piontek, G., Keissling, R. (1986). Selective rejection of H-2 deficient lymphoma variants suggest alternative immune defense strategy. Nature, 319:675-678.
24. Kato, T., Miyamoto, M., Date, T., Yasui, K., Taya, C., Yonekawa, H., Ohue, C., Yagi, S., Seki, E., Hirano, T., Fujimoto, J., Shirai, T., Wakita, T. (2003). Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice. Cancer Science, 94:679-685.
25. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J. M., Hoffmann, J. A. (1996). The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell, 86:973-983.
26. Ljunggren, H. G., Karre, K. (1990). In search on the "missing self": MHC molecules and NK cell recognition. Immunology Today, 11:7-10.
27. Miyagi, T., Tatsumi, T., Takehara, T., Kanto, T., Kuzushita, N., Sugimoto, Y., Jinushi, M., Kasahara, A., Sasaki, Y., Hori, M., Hayashi, N. (2003). Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells. Journal of Gastroenterology and Hepatology, 18:32-40.
28. Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., Koike, K. (1998). The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nature Medicine, 4:1065-1067.
29. Okuda, M., Li, K., Beard, M. R., Showalter, L. A., Scholle, F., Lemon, S. M., Weinman, S. A. (2002). Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology, 122:366-375.
30. Otsuka, M., Kato, N., Taniguchi, H., Yoshida, H., Goto, T., Shiratori, Y., Omata, M. (2002). Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression. Vi ro l o g y, 296:84-93.
31. Palmer, D. H., Hussain, S. A., Johnson, P. J. (2005). Gene- and immunotherapy for hepatocellular carcinoma. Expert Opinion on Biological Therapy, 5:507-523.
32. Prince, A. M., Brotman, B., Grady, G. F., Kuhns, W. J., Hazzi, C., Levine, R. W., Millian, S. J. (1974). Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet, 7875:241-246.
33. Raulet, D. H. (2003). Roles of the NKG2D immunoreceptor and its ligands. Nature Reviews Immunology, 10:781-790.
34. Ravetch, J. V., Lanier, L. L. (2000). Immune inhibitory receptors. Science, 290:84-89.
35. Salih, H. R., Rammensee, H. G., Steinle, A. (2002). Downregulation of MICA on human tumors by proteolytic shedding. Journal of Immunology, 169:4098-4102.
36. Skov, S., Pedersen, M. T., Andresen, L., Straten, P. T., Woetmann, A., Odum, N. (2005). Cancer cell become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. Cancer Research, 65:11136-11145.
37. Smyth, M. J., Hayakawa, Y., Takeda, K., Yagita, H. (2002). New aspects of natural-killer-cell surveillance and therapy of cancer. Nature Reviews Cancer, 2:850-861.
38. Takehara, T., Hayashi, N., Katayama, K., Ueda, K., Towata, T., Kasahara, A., Fusamoto, H., Kamada, T. (1992). Enhanced expression of HLA class I by inhibited replication of hepatitis B virus. Journal of Hepatology, 14:232-236.
39. Takehara, T., Liu, X., Fujimoto, J., Friedman, S. L., Takahashi, H. (2001). Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology, 34:55-61.
40. Takehara, T., Takahashi, H. (2003). Suppression of Bcl-xL deamidation in human hepatocellular carcinomas. Cancer Research, 63:3054-3057.
41. Takehara, T., Hayashi, N. (2005). Natural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity. Clinical Gastroenterology and Hepatology, 3:S78-S81.
42. Trinchieri, G. (1989). Biology of natural killer cells. Advances in Immunology, 47:187-376.